Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 9,027 results for: aav

Clear keywords
Showing: 8701 - 8720 of 9027 results

  5. pAAV-EF1a-4mtGCaMP6f-DIO (AAV1)

    Viral prep
    #179529-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-4mtGCaMP6f-DIO (#179529). In addition to the viral particles, you will also receive purified pAAV-EF1a-4mtGCaMP6f-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GCaMP8f. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Maarten Kole
    Publication
    Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:
    Promoter
    EF1a
    Available since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-EF1a-double floxed-mCherry-WPRE-HGHpA (AAV9)

    Viral prep
    #20299-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-EF1a-double floxed-mCherry-WPRE-HGHpA (#20299). In addition to the viral particles, you will also receive purified pAAV-EF1a-double floxed-mCherry-WPRE-HGHpA plasmid DNA. EF1a-driven, Cre-dependent mCherry expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Tags
    mCherry (Cre-dependent)
    Available since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only

  7. paavCAG-pre-mGRASP-mCerulean (AAV5)

    Viral prep
    #34910-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from paavCAG-pre-mGRASP-mCerulean (#34910). In addition to the viral particles, you will also receive purified paavCAG-pre-mGRASP-mCerulean plasmid DNA. CAG-driven expression of presynaptic mGRASP-mCerulean for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jinhyun Kim
    Publication
    Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi
    Promoter
    CAG
    Tags
    mCerulean
    Available since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-hSyn-eNpHR 3.0-EYFP (AAV2)

    Viral prep
    #26972-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-hSyn-eNpHR 3.0-EYFP (#26972). In addition to the viral particles, you will also receive purified pAAV-hSyn-eNpHR 3.0-EYFP plasmid DNA. hSyn-driven eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Promoter
    Syn
    Available since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV-CAG-GFP (AAV6 trial size)

    Viral prep
    #37825-AAV6.T
    Purpose
    Ready-to-use AAV6 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Promoter
    CAG
    Tags
    GFP
    Available since
    July 16, 2025
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-hSyn-hM3D(Gq)-mCherry (AAV1)

    Viral prep
    #50474-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-hM3D(Gq)-mCherry (#50474). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM3D(Gq)-mCherry plasmid DNA. hSyn-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    mCherry
    Available since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-CAG-2xNLS-tdTomato-WPRE-hGHpolyA (AAV9)

    Viral prep
    #192552-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CAG-2xNLS-tdTomato-WPRE-hGHpolyA (#192552). In addition to the viral particles, you will also receive purified pAAV-CAG-2xNLS-tdTomato-WPRE-hGHpolyA plasmid DNA. CAG-driven expression of nuclear localized tdTomato. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Guoping Feng
    Promoter
    CAG
    Tags
    tdTomato
    Available since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-hSynapsin1-axon-GCaMP6m (AAV9)

    Viral prep
    #111261-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-axon-GCaMP6m (#111261). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-GCaMP6m plasmid DNA. Synapsin-driven expression of calcium sensor GCaMP6m in axons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Lin Tian
    Publication
    Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.
    Promoter
    Syn
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-hSyn-mScarlet (AAV8)

    Viral prep
    #131001-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-hSyn-mScarlet (#131001). In addition to the viral particles, you will also receive purified pAAV-hSyn-mScarlet plasmid DNA. Synapsin-driven mScarlet control vector. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Publication
    Marshel et al Science. 2019 Aug 9;365(6453). pii: scie
    Promoter
    Syn
    Tags
    mScarlet
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  14. pZac2.1-GfaABC1D-lck-jGCaMP8m (AAV1)

    Viral prep
    #176760-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pZac2.1-GfaABC1D-lck-jGCaMP8m (#176760). In addition to the viral particles, you will also receive purified pZac2.1-GfaABC1D-lck-jGCaMP8m plasmid DNA. GfaABC1D-driven expression of membrane-bound calcium sensor GCaMP8m. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Promoter
    GfaABC1D
    Available since
    Feb. 24, 2023
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV.hSynap-FLEX.SF-iGluSnFR.A184V (AAV1)

    Viral prep
    #106181-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.hSynap-FLEX.SF-iGluSnFR.A184V (#106181). In addition to the viral particles, you will also receive purified pAAV.hSynap-FLEX.SF-iGluSnFR.A184V plasmid DNA. Synapsin-driven, Cre-dependent expression of glutamate sensor iGluSnFR (medium affinity). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Publication
    Marvin et al Nat Methods. 2018 Nov;15(11):936-939. do
    Promoter
    Syn
    Available since
    March 19, 2021
    Availability
    Academic Institutions and Nonprofits only

  16. pOTTC1032 - pAAV EF1a Nuc-flox(mCherry)-EGFP (AAV2)

    Viral prep
    #112677-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pOTTC1032 - pAAV EF1a Nuc-flox(mCherry)-EGFP (#112677). In addition to the viral particles, you will also receive purified pOTTC1032 - pAAV EF1a Nuc-flox(mCherry)-EGFP plasmid DNA. EF1a-driven, Cre-dependent color switch. This AAV directs expression of nuclear mCherry in the absence of Cre. In the presence of Cre, nuclear EGFP (and not mCherry) will be expressed. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Brandon Harvey
    Publication
    Back et al Neuron. 2019 Feb 8. pii: S0896-6273(19)3
    Promoter
    EF1a
    Tags
    mCherry (Cre-negative cells), EGFP (Cre-positive cells)
    Available since
    Jan. 17, 2020
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV.hSyn.Flex.iGluSnFr.WPRE.SV40 (AAV5)

    Viral prep
    #98931-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.hSyn.Flex.iGluSnFr.WPRE.SV40 (#98931). In addition to the viral particles, you will also receive purified pAAV.hSyn.Flex.iGluSnFr.WPRE.SV40 plasmid DNA. Synapsin-driven, Cre-dependent, iGluSnFr glutamate sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Publication
    Marvin et al Nat Methods. 2013 Feb;10(2):162-70. doi:
    Promoter
    Syn
    Available since
    Feb. 28, 2018
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV.CAG.Flex.iGluSnFr.WPRE.SV40 (AAV9)

    Viral prep
    #98932-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV.CAG.Flex.iGluSnFr.WPRE.SV40 (#98932). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.iGluSnFr.WPRE.SV40 plasmid DNA. CAG-driven, Cre-dependent glutamate sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Publication
    Marvin et al Nat Methods. 2013 Feb;10(2):162-70. doi:
    Promoter
    CAG
    Available since
    Feb. 28, 2018
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-EF1α-DIO-GtACR2-P2A-Voltron2ST-W3SL (AAV1)

    Viral prep
    #217676-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1α-DIO-GtACR2-P2A-Voltron2ST-W3SL (#217676). In addition to the viral particles, you will also receive purified pAAV-EF1α-DIO-GtACR2-P2A-Voltron2ST-W3SL plasmid DNA. EF1a-driven, Cre-dependent expression of GtACR2 and soma-targeted Voltron2 (ORCHID). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Joseph Raimondo
    Publication
    Selfe et al Nat Commun. 2024 Oct 16;15(1):8913. doi:
    Promoter
    EF‐1α
    Available since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-EFS-SpCas9 (AAV8)

    Viral prep
    #104588-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EFS-SpCas9 (#104588). In addition to the viral particles, you will also receive purified pAAV-EFS-SpCas9 plasmid DNA. EFS-driven expression of Myc-tagged SpCas9. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Ryohei Yasuda
    Publication
    Nishiyama et al Neuron. 2017 Oct 18. pii: S0896-6273(17)
    Promoter
    EFS
    Available since
    Jan. 14, 2026
    Availability
    Academic Institutions and Nonprofits only
Showing: 8701 - 8720 of 9027 results